PLRX — PLIANT THERAPEUTICS INC

Ownership history in Rangeley Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which Rangeley Capital, LLC reported a position in PLIANT THERAPEUTICS INC (PLRX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.23% (2025 Q4)
Avg. % of fund
0.12%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 225,000 +164,780 +273.6% 0.23% $274K $1.22
2025 Q3 UNCHANGED 60,220 — 0% 0.08% $89K $1.48
2025 Q2 ADDED 60,220 +10,220 +20.4% 0.08% $70K $1.16
2025 Q1 INITIATED 50,000 — — 0.07% $68K $1.35
% of Fund (quarterly)    PLRX price (monthly, adj. close)

Other funds also holding PLRX

As of 2025 Q4 — sorted by position size

BML Capital Management, LLC 3Y 1.63% Monaco Asset Management SAM 3Y 0.41% Prosight Management, LP 3Y 7Y 0.39% TANG CAPITAL MANAGEMENT LLC 3Y 7Y 0.37% Blue Owl Capital Holdings LP 3Y 0.27% Seven Fleet Capital Management LP 0.26% NANO CAP NEW MILLENNIUM GROWTH FUND L P 0.24% Stonepine Capital Management, LLC 3Y 7Y 0.2% Redmile Group, LLC 3Y 7Y 0.15% TORNO CAPITAL, LLC 0.09%
← Back to Rangeley Capital, LLC Holdings